Opticrom

Active Ingredient(s): Cromolyn Sodium
FDA Approved: * October 3, 1984
Pharm Company: * ALLERGAN
Category: Asthma

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".

Opticrom Overview

Cromoglicic acid (INN) (also referred to as cromolyn (USAN), cromoglycate (former BAN), or cromoglicate) is traditionally described as a mast cell stabilizer, and is commonly marketed as the sodium salt sodium cromoglicate or cromolyn sodium. This drug prevents the release of inflammatory chemicals such as histamine from mast cells. Cromoglicic acid has been the non-corticosteroid treatment of choice in the treatment of asthma, for which it has largely been replaced by leukotriene receptor a...

Read more Opticrom Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Cromoglicic_acid

Recent Opticrom Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

Other drugs which contain Cromolyn Sodium or a similar ingredient: (7 results)

• CROLOM Cromolyn Sodium
• CROMOLYN SODIUM 1 discussion
• CROMOPTIC Cromolyn Sodium
• GASTROCROM Cromolyn Sodium6 discussions
• INTAL Cromolyn Sodium
• INTAL INHALER Cromolyn Sodium
• NASALCROM Cromolyn Sodium1 discussion